ReviewCurrent diabetes reviews2016

Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and Efficacy.

Scott R DrabPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.